In the future studies of patients with neurodegenerative diseases or animal models of neurological disorders, manipulation of Shh signaling and alteration of autophagy by pharmacological or molecular approaches will improve our understanding towards these diseases and may guide the way to novel methods for their prevention and treatment. This evidence concerns the gene SHH and nervous system disorder.